Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data.

Journal: Annals of surgical oncology
Published Date:

Abstract

BACKGROUND: Lung cancer poses a global health threat necessitating early detection and precise staging for improved patient outcomes. This study focuses on developing and validating a machine learning-based risk model for early lung cancer screening and staging, using routine clinical data.

Authors

  • Wei Wei
    Dept. Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Yun Wang
    Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.
  • Renren Ouyang
    Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ting Wang
    CAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
  • Rujia Chen
    Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xu Yuan
    School of Software, Dalian University of Technology, Dalian, Liaoning, China david@dlut.edu.cn.
  • Feng Wang
    Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Shiji Wu
    Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Hongyan Hou
    Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tjhouhongyan@tjh.tjmu.edu.cn.